Stephanie Best

Stephanie Best is an Assistant Controller at Ensoma with a strong background in accounting within the biotechnology industry. Her career includes progressive roles at Vor Biopharm and BioNTech. She holds an MBA from Northeastern University and a Bachelor of Science from the University of Massachusetts Amherst, underscoring her financial expertise in the life sciences sector.

Stephanie is a proud and active supporter of her alma mater, UMass Amherst, especially its athletic programs. Her interests also extend to community well-being and healthcare advancement, demonstrated by her engagement with organizations like the Network for Excellence in Health Innovation (NEHI) and NVNA and Hospice.

She has navigated companies through significant growth and transitions, including BioNTechs acquisition of Neon Therapeutics.